SFTS bunyavirus NSs protein sequestrates mTOR into inclusion bodies and deregulates mTOR‐ULK1 signaling, provoking pro‐viral autophagy

Kuan Feng,Huijiao Zhang,Zhenyu Jiang,Min Zhou,Yuan‐Qin Min,Fei Deng,Peiqing Li,Hualin Wang,Yun‐Jia Ning
DOI: https://doi.org/10.1002/jmv.28371
IF: 20.693
2022-12-04
Journal of Medical Virology
Abstract:Autophagy is emerging as a critical player in host defense against diverse infections, in addition to its conserved function to maintain cellular homeostasis. Strikingly, some pathogens have evolved strategies to evade, subvert or exploit different steps of the autophagy pathway for their lifecycles. Here, we present a new viral mechanism of manipulating autophagy for its own benefit with severe fever with thrombocytopenia syndrome bunyavirus (SFTSV, an emerging high‐pathogenic virus) as a model. SFTSV infection triggers autophagy, leading to complete autophagic flux. Mechanistically, we show that the nonstructural protein of SFTSV (NSs) interacts with mTOR, the pivotal regulator of autophagy, by targeting its kinase domain and captures mTOR into viral inclusion bodies (IBs) induced by NSs itself. Furthermore, NSs impairs mTOR‐mediated phosphorylation of unc‐51‐like kinase 1 (ULK1) at Ser757, disrupting the inhibitory effect of mTOR on ULK1 activity and thus contributing to autophagy induction. Pharmacologic treatment and Beclin‐1 knockout experimental results establish that, in turn, autophagy enhances SFTSV infection and propagation. Moreover, minigenome reporter system reveals that SFTSV ribonucleoprotein (the transcription and replication machinery) activity can be bolstered by autophagy. Additionally, we found that the NSs proteins of SFTSV‐related bunyaviruses have conserved function of targeting to mTOR. Together, we unravel a viral strategy of inducing pro‐viral autophagy by interacting with mTOR, sequestering mTOR into IBs and hence provoking the downstream ULK1 pathway, which presents a new paradigm for viral manipulation of autophagy and may help inform future development of specific antiviral therapies against SFTSV and related pathogens. This article is protected by copyright. All rights reserved.
virology
What problem does this paper attempt to address?